Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122648) titled 'A Comparative Study of the Efficacy and Safety of the ACHP-THP Regimen and TCbHP Regimen in Neoadjuvant Therapy for Hormone Receptor-Positive HER2-Positive Breast Cancer' on April 16.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangxi Medical University Cancer Hospital
Condition:
breast cancer
Intervention:
TCbHP regimen group:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-05-01
Target Sample Size: TCbHP regimen group:90;ACHP-THP regimen group:30;
Countries of Recruitment:
China
To know more, visit https://www.ch...